The Treatment with Mycophenolate Mofetil of Corticoresistent Nephrotic Syndrome by Idiopathic Focal Segmental Glomerulosclerosis: Analysis of Twenty Cases

Author:

Rroji Merita1,Spahia Nereida1,Barbullushi Myftar1,Sasdelli Mauro2

Affiliation:

1. Service of Nephrology , University Hospital Centre “Mother Teresa” , Tirana , Albania

2. Ex Chief of Nephrology Department of St. Donato Hospital , Arezzo , Italy

Publisher

Walter de Gruyter GmbH

Subject

General Medicine

Reference14 articles.

1. 1. D’Agati VD, et al: Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 2013; 43: 368–382.

2. 2. Parsa A, et al: APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 2013; 369: 2183–2196.10.1056/NEJMoa1310345

3. 3. Deegens JKJ: Immunosuppressive treatment of focal segmental glomerulosclerosis: lessons from a randomized controlled trial. Kidney Int 2011; 80: 798–01.10.1038/ki.2011.191

4. 4. Alfonso Segarra Medrano et al: Treatment of idiopathic focal segmental glomerulosclerosis: options in the event of resistance to corticosteroids and calcineurin inhibitors. Nefrologia 2013; 33 (4): 443–622.

5. 5. Cattran, D.C, et al: Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis. Clin Nephrol 2004; 62: 405–411.10.5414/CNP62405

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3